|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$91,977.93 |
2.85% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$89,983.40 |
2.79% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$87,263.50 |
2.70% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$82,659.75 |
2.56% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$82,267.84 |
2.55% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$79,986.33 |
2.48% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$80,017.18 |
2.48% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$78,416.64 |
2.43% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$77,286.80 |
2.40% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$76,763.88 |
2.38% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$76,195.89 |
2.36% |
| Waters Corporation |
WAT |
941848103 |
184 |
$75,839.28 |
2.35% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$75,441.75 |
2.34% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$75,170.86 |
2.33% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$74,790.44 |
2.32% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$72,408.00 |
2.24% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$70,058.80 |
2.17% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$69,341.20 |
2.15% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$69,470.87 |
2.15% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$69,418.22 |
2.15% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$68,310.66 |
2.12% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$65,818.30 |
2.04% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$65,415.00 |
2.03% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$63,855.90 |
1.98% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$63,711.45 |
1.97% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$63,305.45 |
1.96% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$62,759.50 |
1.95% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$63,068.76 |
1.95% |
| Steris Plc |
STE |
G8473T100 |
265 |
$61,819.20 |
1.92% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$61,645.40 |
1.91% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$61,698.52 |
1.91% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$60,573.47 |
1.88% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$59,467.83 |
1.84% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$59,022.54 |
1.83% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$58,130.07 |
1.80% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$58,209.56 |
1.80% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$57,910.68 |
1.80% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$56,739.99 |
1.76% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$56,408.32 |
1.75% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$56,006.80 |
1.74% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$53,577.16 |
1.66% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$52,151.64 |
1.62% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$51,286.30 |
1.59% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$49,497.65 |
1.53% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$49,153.74 |
1.52% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$47,187.48 |
1.46% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$45,810.14 |
1.42% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$43,002.00 |
1.33% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$42,343.32 |
1.31% |
| US Dollar |
$USD |
|
13,565 |
$13,565.44 |
0.42% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|